Resmed share price logo

Resmed

NASDAQ: RMD

Large Cap

$229.47

+9.49

(+4.31%)

Live

as on

Resmed Stock Performance

as on August 20, 2026 at 5:07 am IST

  • Day's Low

    Day's High

    $222.00
    $230.02
    downward going graph

    3.26%

    Downside

    0.24%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $180.27
    $293.81
    downward going graph

    21.44%

    Downside

    28.04%

    Upside

    downward going graph

Resmed share price movements today

Previous Close
$219.98
Open
$223.08
Volume
690.8K
Market Cap
$32.4B
Dividend Yield
1.06%
Day's Low - High
$222.00 - $230.02
52 Week Low - High
$180.27 - $293.81

Resmed Historical Returns

1 Month Return
+ 12.8 %
3 Month Return
+ 11.18 %
1 Year Return
-21.21 %
3 Year Return
+ 36.2 %
5 Year Return
-20.01 %

Resmed Stock Fundamentals & Key Indicators

Check Resmed market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$32.4B

EPS (TTM)

10.44

Dividend Yield

1.06%

Quarterly Earnings Growth YOY

0.02%

PE Ratio (TTM)

21.72

Industry PE ratio

21.7325

PEG Ratio

2.330456541392233

EBITDA

2.1B

Revenue (TTM)

5.7B

Profit Margin

61.16%

Return On Equity TTM

23.88%

Resmed Stock Valuation

Track how Resmed P/E has moved over time to understand its valuation trends.

Resmed in the last 5 years

  • Overview

  • Trends

Lowest (18.67x)

June 30, 2026

Today (18.67x)

June 30, 2026

Industry (21.73x)

June 30, 2026

Highest (39.28x)

June 30, 2022

LowHigh

Today’s Price to Earnings Ratio: 18.67x

Resmed vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Resmed with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
BUY$32.4B-20.01%21.7261.16%1.06%
BUY$141.3B14.35%45.3466.68%NA
BUY$35.9B4.05%56.685.92%48.870000000000005%
BUY$50.0B-27.65%54.8146.12%2.06%
StrongBuy$48.1BNA44.672.32%NA

Stock Returns calculator for Resmed Stock including INR - Dollar returns

The Resmed stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Resmed investment value today

Current value as on today

₹88,570

Returns

-₹11,430

(-11.43%)

Returns from Resmed Stock

-₹19,453 (-19.45%)

Dollar Impact

₹8,023 (+8.02%)

Analyst Recommendation on Resmed Stock

Based on 14 analysts

BUY

28.57%

Buy

71.43%

Hold

0.00%

Sell

Based on 14 analysts, 71.42857142857143% of analysts recommend a 'BUY' rating for Resmed. Average target price of $247.2

Resmed Share Price Target

Get share price movements and forecasts by analysts on Resmed.

What analysts predicted

7.17%UPSIDE

Target Price

$247.2

Current Price

$229.47

Analyzed by

14 Analysts

Target

$247.20

Resmed target price $247.2, a slight upside of 7.17% compared to current price of $229.47. According to 14 analysts rating.

Indian Investors' Interest in Resmed Stock

Search interest for Resmed Stock has increased by 30% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:30% versus previous 30 day period

Resmed Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
1,196
1,223
1,224
1,282
1,291
1,347
1,335
1,422
1,431
1,463
Gross Profit
681
704
717
751
766
820
820
884
890
861
Operating Income
374
381
387
417
426
454
446
497
499
448
EBITDA
444
362
442
479
469
532
503
566
583
492
Interest Expense
14
9
5
4
3
-
8
7
12
-
Depreciation
54
54
53
55
51
74
47
62
69
18
Income Before Tax
375
357
383
418
417
458
446
496
502
474
Income Tax Expense
74
65
72
73
52
78
98
103
103
90
Net Income
300
292
311
344
365
379
348
392
398
383
Net Profit Margin
56.94%
57.58%
58.57%
58.60%
59.33%
60.84%
61.46%
62.18%
62.25%
58.84%

Resmed Annual Profit & Loss

All numbers in Millions USD

Jun 2017
Jun 2018
Jun 2019
Jun 2020
Jun 2021
Jun 2022
Jun 2023
Jun 2024
Jun 2025
Jun 2026
Total Revenue
2,066
2,340
2,606
2,957
3,196
3,578
4,222
4,685
5,146
5,653
Gross Profit
1,201
1,362
1,536
1,717
1,839
2,024
2,355
2,655
3,054
3,457
Operating Income
425
541
579
809
903
1,000
1,131
1,319
1,685
1,892
EBITDA
568
680
705
990
1,103
1,176
1,358
1,533
1,913
2,146
Interest Expense
28
28
36
40
23
22
47
45
12
29
Depreciation
112
119
150
181
191
193
196
216
235
197
Income Before Tax
418
521
518
733
883
960
1,101
1,264
1,677
1,919
Income Tax Expense
76
205
114
111
409
181
204
243
276
396
Net Income
342
315
404
621
474
779
897
1,020
1,400
1,523
Net Profit Margin
58.15%
58.21%
58.95%
58.09%
57.53%
56.57%
55.78%
56.67%
59.36%
61.16%

Resmed Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
300
292
311
344
365
379
348
392
398
1,523
Operating Cash Flow
402
440
325
308
578
538
457
339
554
1,805
Investing Cash Flow
-33
-46
2
-36
-31
-133
-52
-50
-58
-545
Financing Cash Flow
-335
-393
-150
-147
-144
-163
-230
-258
-255
-1,007
Change in Cash
27
0
188
95
410
276
174
33
243
259

Resmed Annual Cash Flow

All numbers in Millions USD

Jun 2017
Jun 2018
Jun 2019
Jun 2020
Jun 2021
Jun 2022
Jun 2023
Jun 2024
Jun 2025
Jun 2026
Net Income
342
315
404
621
474
779
897
1,020
1,400
1,523
Operating Cash Flow
414
505
459
802
736
351
693
1,401
1,751
1,805
Investing Cash Flow
-81
-101
-1,075
-179
-158
-229
-1,159
-269
-200
-545
Financing Cash Flow
-262
-1,026
580
-317
-764
-128
422
-1,119
-606
-1,007
Change in Cash
90
-633
-41
316
-167
-21
-45
10
971
259

Mutual Funds that own Resmed Stock

Check out the Mutual Funds with significant holdings in Resmed.

Funds
Holdings
Shares Held
VANGUARD INDEX FUNDS
9.996858%
14501081
Fidelity Concord Street Trust
1.711425%
2482532
Fidelity Salem Street Trust
0.841621%
1220825
VANGUARD INSTITUTIONAL INDEX FUNDS
0.614611%
891533
VANGUARD SPECIALIZED FUNDS
0.563862%
817918

Global Institutional Holdings in Resmed

Funds
Holdings
Vanguard
11.59%
iShares
5.66%
SPDR
4.02%
Invesco
1.77%
First Trust
1.67%

Resmed News & Key Events

    Insights on Resmed

    Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

    • imgPOSITIVE IMPACT

      Best in 3 Years

      img

      In the last 3 years, RMD has outperformed top 5 stocks with highest market-cap in its industry

    • imgPOSITIVE IMPACT

      Price Rise

      img

      In the last 1 month, RMD stock has moved up by 10.5%

    • imgPOSITIVE IMPACT

      Revenue Rich

      img

      Revenue is up for the last 4 quarters, 1.33B → 1.46B (in $), with an average increase of 3.0% per quarter

    • imgNO EFFECT

      Against Peers

      img

      In the last 1 year, ResMed Inc. has experienced a drawdown of -23.1%, however Becton, Dickinson and Co. resisted the overall trend and outperformed by 14.4%

    • imgNEGATIVE IMPACT

      Profit Down

      img

      Netprofit is down for the last 2 quarters, 398.73M → 383.43M (in $), with an average decrease of 3.8% per quarter

    About Resmed

    ResMed Inc. engages in the digital health and cloud-connected medical devices business in the United States and internationally. It operates in two segments, Sleep and Breathing Health, and Residential Care Software. The company offers sleep recorders for the diagnosis and titration of sleep apnea in sleep clinics, hospitals, and at home, including ApneaLink Air, a portable diagnostic device that measures oximetry, respiratory effort, pulse, nasal flow, and snoring; NightOwl, a portable, cloud-connected, and disposable diagnostic device that measures AHI based on derived peripheral arterial tone, actigraphy, and oximetry; and EasyCare Tx, a sleep lab solution. It also provides AirView, a cloud-based system that enables remote monitoring and changing of patients' device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; and connectivity module which provides a cellular connection between compatible ventilation devices and AirView system. In addition, the company offers Brightree solutions which are solutions and services for organizations in home medical equipment and pharmacy, orthotic and prosthetic, and home infusion; HEALTHCAREfirst solutions that offers electronic health record, software, billing and coding services, and advanced analytics that enables home health and hospice agencies to optimize clinical, financial and administrative processes; MatrixCare EHR software as a service solutions used by skilled nursing and senior living providers, life plan communities, and home health and hospice sectors; and MEDIFOX DAN software solutions that is used by residential care providers, such as home health and nursing home providers. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.
    OrganisationResmed
    Headquarters9001 Spectrum Center Boulevard, San Diego, CA, United States, 92123
    IndustryMedical Instruments & Supplies
    CEOMr. Michael J. Farrell BE, MBA, SM
    E-voting on sharesClick here to vote

    Key Management of Resmed

    Name

    Title

    Dr. Peter C. Farrell A.M., B.E., BE (Hons), Ph.D., ScD

    Founder, Chair Emeritus & Non-Executive Director

    Mr. Michael J. Rider

    Chief Legal Officer & Secretary

    Mr. Aaron Bloomer

    Chief Financial Officer

    Ms. Vered Keisar

    Chief People Officer

    Mr. Michael J. Farrell BE, MBA, SM

    CEO & Chairman

    Mr. Brett A. Sandercock

    Advisor

    Mr. Alastair Robertson

    Chief Information Officer

    Ms. Sallilyn Schwartz

    Chief Investor Relations Officer

    Mr. Jim Ellis

    Chief Compliance Officer

    Ms. Yvonne-Katrin Pucknat

    Chief Marketing Officer

    FAQs

    What is Resmed share price today?

    Resmed share price today is $229.47 as on . Resmed share today touched a day high of $230.02 and a low of $222.00.

    What is the 52 week high and 52 week low for Resmed share?

    Resmed share touched a 52 week high of $293.81 on and a 52 week low of $180.27 on . Resmed stock price today i.e. is trending at $229.47,which is 21.90% down from its 52 week high and 27.30% up from its 52 week low.

    What is Resmed's market capitalisation today?

    Resmed market capitalisation is $0.03T as on .

    How to invest in Resmed Stock (RMD) from India?

    1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
    2. Step 2: Search for Resmed on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Resmed Shares that will get you 0.0065 shares as per Resmed share price of $229.47 per share as on August 19, 2026 at 11:37 pm IST.

    What is the minimum amount required to buy Resmed Stock (RMD) from India?

    Indian investors can start investing in Resmed (RMD) shares with as little as ₹95.743 or $1 (as of ) using the INDmoney app.
    For example: If you want to invest $10 or ₹957.43 in Resmed stock (as per the Rupee-Dollar exchange rate as on ). Based on Resmed share’s latest price of $229.47 as on August 19, 2026 at 11:37 pm IST, you will get 0.0436 shares of Resmed. Learn more about fractional shares .

    What are the returns that Resmed has given to Indian investors in the last 5 years?

    Resmed stock has given -20.01% share price returns and 28.54% dollar appreciation to an Indian investor in the last 5 years.
    Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?